XBIT (xbiotech.com) Earnings per share growth rate in current year
Under the leadership of John Simbard, XBiotech Inc. (XBIT) maintains strategic resilience and a debt-free balance sheet. The annual growth of net earnings per share as a percentage demonstrates a development trend, where the indicator settled at 0.00. XBiotech Inc. (XBIT) is investing billions into the creation of True Human antibodies for cancer therapy. However, high R&D costs are causing a constant capital outflow until the commercialization of licenses.
Analytical breakdowns and data insights for company xbiotech.com (XBIT)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and solvency information:
- earnings and market ratios statistics:
XBIT - Net Profit|Expected Net Income XBiotech Inc.|XBIT - Price to Earnings Ratio|Future Price to Earnings Multiple XBiotech|XBIT - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio XBIT|XBIT - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months XBiotech|XBIT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months xbiotech.com|XBIT - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year XBiotech Inc.
Summary company analysis:XBiotech USA - XBIT
XBiotech Inc. is scaling antibody screening automation through the implementation of robotic systems. By analyzing the year-over-year shift in EPS, an investor can observe the dynamics of net profit per share. The current value of 0.00 reflects the annual capital growth rate relative to the previous period. This metric measures the efficiency of R&D process monetization. This trend determines the fundamental valuation stability of the business within the oncology drug sector.
Direct competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Net earnings per share growth this year AAPG (Ascentage Pharma Group)|cgoncology.com - Earnings per share growth this year|Earnings growth in current year URGN (UroGen Pharma)|Bicara Therapeutics Inc - Earnings per share growth in current year|Personalis Corp - Earnings growth in current year|Expected net earnings per share growth this year Erasca Oncology ERAS|Delcath Systems, Inc. (DCTH) - Earnings per share growth in current year|Earnings per share growth rate in current year ymabs.com (YMAB)|Net earnings per share growth this year AURA|CADL (Candel) - Net earnings per one share growth for the current year|Earnings growth in current year ARAY|SLS - Earnings per share growth rate in current year|Earnings growth in current year ACTU (Actuate Therapeutics, Inc.)|CTOR - Net earnings per share growth this year|TuHURA - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics Inc)|FATE (Fate Therapeutics Corp) - Net earnings per share growth this year|Aadi Bioscience - Earnings per share increase in current year|TCRX (TScan Therapeutics Inc) - Earnings growth in current year|Champions Oncology Corp (CSBR) - Expected net earnings per share growth this year|Earnings per share growth in current year CEL-SCI Corporation (CVM)|OS Therapies Inc. - Earnings per share growth this year|Earnings growth in current year RADX (Radiopharm Theranostics)|ARTV - Net earnings per share growth this year|ANL: Net earnings per share growth this year|Expected net earnings per share growth this year verupharma.com VERU|TPST (Tempest Therapeutics, Inc.) - Net earnings per share growth this year|Earnings per share growth this year XLO|RENB (Renovaro Biosciences) - Earnings growth in current year|Earnings per share growth in current year MURA|Earnings growth in current year KAPA|Expected net earnings per share growth this year onkuretherapeutics.com|CytoMed Therapeutics Limited - Net earnings per share growth this year|Net earnings per one share growth for the current year CRIS (Curis Inc.)|Apollomics Corp - Earnings growth in current year|Tharimmune Corporation (THAR) - Net earnings per share growth this year|ADVB: Earnings growth in current year|genprex.com (GNPX) - Earnings growth in current year|Earnings per share growth in current year Calidi Biotherapeutics Inc.|Earnings per share growth this year SBFM (sunshinebiopharma.com)|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharma SLRX|Earnings growth in current year PPBT (Purple Biotech)|American Oncology Network Inc (AONC) - Earnings per share growth rate in current year|BGNE - Earnings per share growth in current year|Earnings per share increase in current year CKPT (Checkpoint Therapeutics Inc.)|ELEV (Elevation Oncology) - Net earnings per share growth this year|iCAD - Earnings per share increase in current year|IKNA (Ikena Oncology Inc.) - Earnings growth in current year|Net earnings per share growth this year notablelabs.com (NTBL)|Net earnings per share growth this year VIRX (Viracta Therapeutics)|Earnings growth in current year MorphoSys Inc (MOR)|Earnings per share growth in current year NAYA Bio NAYA|Earnings per share increase in current year AAPGV
